Erik Iverson

2.6k total citations · 1 hit paper
8 papers, 1.8k citations indexed

About

Erik Iverson is a scholar working on Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Erik Iverson has authored 8 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Erik Iverson's work include Influenza Virus Research Studies (3 papers), Respiratory viral infections research (2 papers) and Cardiac pacing and defibrillation studies (2 papers). Erik Iverson is often cited by papers focused on Influenza Virus Research Studies (3 papers), Respiratory viral infections research (2 papers) and Cardiac pacing and defibrillation studies (2 papers). Erik Iverson collaborates with scholars based in United States, Canada and United Kingdom. Erik Iverson's co-authors include Susan Anderson, Peter E. Carson, Barry M. Massie, Robert S. McKelvie, Agata Ptaszynska, Mark Donovan, C Staiger, John J.V. McMurray, Michel Komajda and Michael R. Zile and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American College of Cardiology.

In The Last Decade

Erik Iverson

8 papers receiving 1.8k citations

Hit Papers

Irbesartan in Patients with Heart Failure and Preserved E... 2008 2026 2014 2020 2008 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Iverson United States 8 1.4k 266 165 157 146 8 1.8k
Massimo Mancone Italy 23 663 0.5× 106 0.4× 128 0.8× 104 0.7× 224 1.5× 73 1.4k
Parul Tandon Canada 16 1.4k 1.0× 74 0.3× 183 1.1× 248 1.6× 347 2.4× 48 2.2k
Amir Kashani United States 17 657 0.5× 139 0.5× 206 1.2× 170 1.1× 115 0.8× 42 1.5k
Isabelle Antony France 18 953 0.7× 126 0.5× 153 0.9× 164 1.0× 118 0.8× 39 1.5k
B. Frigerio Italy 13 376 0.3× 169 0.6× 134 0.8× 121 0.8× 75 0.5× 27 846
A. Ravani Italy 13 432 0.3× 85 0.3× 132 0.8× 174 1.1× 67 0.5× 31 808
Maximilian T. Lobmeyer United States 14 1.1k 0.8× 141 0.5× 231 1.4× 87 0.6× 222 1.5× 26 1.6k
Claudio Gimpelewicz Switzerland 18 731 0.5× 197 0.7× 155 0.9× 218 1.4× 52 0.4× 42 1.2k
Louis Rakita United States 21 896 0.6× 164 0.6× 159 1.0× 203 1.3× 382 2.6× 32 1.8k
James Burton United States 19 588 0.4× 172 0.6× 60 0.4× 239 1.5× 451 3.1× 50 1.4k

Countries citing papers authored by Erik Iverson

Since Specialization
Citations

This map shows the geographic impact of Erik Iverson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Iverson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Iverson more than expected).

Fields of papers citing papers by Erik Iverson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Iverson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Iverson. The network helps show where Erik Iverson may publish in the future.

Co-authorship network of co-authors of Erik Iverson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Iverson. A scholar is included among the top collaborators of Erik Iverson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Iverson. Erik Iverson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Silverman, Adam D., Khalid K. Alam, Erik Iverson, et al.. (2019). Design of a Transcriptional Biosensor for the Portable, On-Demand Detection of Cyanuric Acid. ACS Synthetic Biology. 9(1). 84–94. 53 indexed citations
2.
Spaulding, Alicen B., Alan R. Lifson, Erik Iverson, et al.. (2012). Gonorrhoea or chlamydia in a US military HIV-positive cohort. Sexually Transmitted Infections. 88(4). 266–271. 19 indexed citations
3.
Crum‐Cianflone, Nancy F., Erik Iverson, Gabriel Defang, et al.. (2011). Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine. 29(17). 3183–3191. 44 indexed citations
4.
Crum‐Cianflone, Nancy F., Gary Collins, Gabriel Defang, et al.. (2011). Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults. Clinical & Experimental Immunology. 168(1). 135–141. 14 indexed citations
5.
Crum‐Cianflone, Nancy F., Lynn E. Eberly, Christopher Duplessis, et al.. (2010). Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine in an Immunocompromised Population: A Prospective Study Comparing HIV-Infected Adults with HIV-Uninfected Adults. Clinical Infectious Diseases. 52(1). 138–146. 83 indexed citations
6.
Baron, John A., Robert S. Sandler, Robert S. Bresalier, et al.. (2008). Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. The Lancet. 372(9651). 1756–1764. 158 indexed citations
7.
Massie, Barry M., Peter E. Carson, John J.V. McMurray, et al.. (2008). Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. New England Journal of Medicine. 359(23). 2456–2467. 1362 indexed citations breakdown →
8.
Alexander, Karen P., L. Kristin Newby, Susan Anderson, et al.. (2007). Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction. Journal of the American College of Cardiology. 49(13). 1450–1458. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026